DEFINITIVE PROXY

Company

ACTUATE THERAPEUTICS, INC.

Filed

April 8, 2025

Period of Report

May 22, 2025

Accession Number

0001683168-25-002344

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →